Pharmacological Treatment of Obstructive Sleep Apnea

被引:0
作者
Abad, Vivien C. [1 ]
Guilleminault, Christian [2 ]
机构
[1] Palo Alto Fdn, Sleep Disorders Ctr, Palo Alto, CA USA
[2] Stanford Univ, Stanford Sleep Med Program, Redwood City, CA USA
关键词
Obstructive sleep apnea; treatment; pharmacotherapy; targets; CPAP; HISTAMINE H-3 RECEPTOR; WAKE DISORDERS; CSF HISTAMINE; TARGET; ANTAGONISTS; NARCOLEPSY; LIGANDS; AGONIST; RATS; MICE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Obstructive sleep apnea (OSA) is a growing public health hazard fueled by the obesity epidemic and an aging population. Untreated sleep apnea can result in significant consequences both in the short-term and long-term. We need to educate the public to recognize the symptoms of sleep apnea and to publicize that effective treatments are available. Positive airway pressure therapy remains the gold standard currently in treating OSA. Alternative treatments include an oral appliance or surgical options. This paper discusses the pharmacologic treatment of sleep apnea: goals include medications to address the ventilatory control of breathing, treat co-morbid diseases, treat associated health problems/complaints, address special issues, such as anesthetic precautions, and propose future targets.
引用
收藏
页码:1418 / 1429
页数:12
相关论文
共 18 条
[1]  
Barbier A. J., 2007, CNS & Neurological Disorders-Drug Targets, V6, P31, DOI 10.2174/187152707779940790
[2]  
BERTACCINI G, 1991, ALIMENT PHARM THERAP, V5, P585
[3]   Histamine H3 receptor antagonists:: From target identification to drug leads [J].
Bonaventure, P. ;
Letavic, M. ;
Dugovic, C. ;
Wilson, S. ;
Aluisio, L. ;
Pudiak, C. ;
Lord, B. ;
Mazur, C. ;
Kamme, F. ;
Nishino, S. ;
Carruthers, N. ;
Lovenberg, T. .
BIOCHEMICAL PHARMACOLOGY, 2007, 73 (08) :1084-1096
[4]  
BRODERICK M, 2011, SLEEPINESS CAUSES CO
[5]   The challenge of drug discovery of a GPCR target:: Analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists [J].
Hancock, AA .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (08) :1103-1113
[6]  
KATZUNG B, 2009, CLIN PHARM
[7]   Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists [J].
Le, Siyuan ;
Gruner, John A. ;
Mathiasen, Joanne R. ;
Marino, Michael J. ;
Schaffhauser, Herve .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (03) :902-909
[8]   An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy:: Studies in orexin-/- mice and patients [J].
Lin, Jian-Sheng ;
Dauvilliers, Yves ;
Arnulf, Isabelle ;
Bastuji, Helene ;
Anaclet, Chnistelle ;
Parmentier, Regis ;
Kocher, Laurence ;
Yanagisawa, Masashi ;
Lehert, Philippe ;
Ligneau, Xavier ;
Perrin, David ;
Robert, Philippe ;
Roux, Michel ;
Lecomte, Jeanne-Marie ;
Schwartz, Jean-Charles .
NEUROBIOLOGY OF DISEASE, 2008, 30 (01) :74-83
[9]   INVOLVEMENT OF HISTAMINERGIC NEURONS IN AROUSAL MECHANISMS DEMONSTRATED WITH H-3 RECEPTOR LIGANDS IN THE CAT [J].
LIN, JS ;
SAKAI, K ;
VANNIMERCIER, G ;
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC ;
JOUVET, M .
BRAIN RESEARCH, 1990, 523 (02) :325-330
[10]   Cloning and functional expression of the human histamine H3 receptor [J].
Lovenberg, TW ;
Roland, BL ;
Wilson, SJ ;
Jiang, XX ;
Pyati, J ;
Huvar, A ;
Jackson, MR ;
Erlander, MG .
MOLECULAR PHARMACOLOGY, 1999, 55 (06) :1101-1107